627 related articles for article (PubMed ID: 20202514)
1. Impact of olmesartan on progression of coronary atherosclerosis a serial volumetric intravascular ultrasound analysis from the OLIVUS (impact of OLmesarten on progression of coronary atherosclerosis: evaluation by intravascular ultrasound) trial.
Hirohata A; Yamamoto K; Miyoshi T; Hatanaka K; Hirohata S; Yamawaki H; Komatsubara I; Murakami M; Hirose E; Sato S; Ohkawa K; Ishizawa M; Yamaji H; Kawamura H; Kusachi S; Murakami T; Hina K; Ohe T
J Am Coll Cardiol; 2010 Mar; 55(10):976-82. PubMed ID: 20202514
[TBL] [Abstract][Full Text] [Related]
2. Four-year clinical outcomes of the OLIVUS-Ex (impact of Olmesartan on progression of coronary atherosclerosis: evaluation by intravascular ultrasound) extension trial.
Hirohata A; Yamamoto K; Miyoshi T; Hatanaka K; Hirohata S; Yamawaki H; Komatsubara I; Hirose E; Kobayashi Y; Ohkawa K; Ohara M; Takafuji H; Sano F; Toyama Y; Kusachi S; Ohe T; Ito H
Atherosclerosis; 2012 Jan; 220(1):134-8. PubMed ID: 22119063
[TBL] [Abstract][Full Text] [Related]
3. Impact of angiotensin II receptor blocker therapy (olmesartan or valsartan) on coronary atherosclerotic plaque volume measured by intravascular ultrasound in patients with stable angina pectoris.
Ishii H; Kobayashi M; Kurebayashi N; Yoshikawa D; Suzuki S; Ichimiya S; Kanashiro M; Sone T; Tsuboi H; Amano T; Uetani T; Harada K; Marui N; Murohara T
Am J Cardiol; 2013 Aug; 112(3):363-8. PubMed ID: 23623047
[TBL] [Abstract][Full Text] [Related]
4. Olmesartan reduces inflammatory biomarkers in patients with stable coronary artery disease undergoing percutaneous coronary intervention: results from the OLIVUS trial.
Miyoshi T; Hirohata A; Usui S; Yamamoto K; Murakami T; Komatsubara I; Kusachi S; Ohe T; Nakamura K; Ito H
Heart Vessels; 2014 Mar; 29(2):178-85. PubMed ID: 23563752
[TBL] [Abstract][Full Text] [Related]
5. Plaque burden with composition? That is the next question.
Marso SP
J Am Coll Cardiol; 2010 Mar; 55(10):983-5. PubMed ID: 20202515
[No Abstract] [Full Text] [Related]
6. Effects of aliskiren in diabetic and non-diabetic patients with coronary artery disease: Insights from AQUARIUS.
Puri R; Nissen SE; Menon V; Shao M; Hsu A; Bakris GL; Kastelein JJ; Williams B; Armbrecht J; Brunel P; Kataoka Y; Nicholls SJ
Atherosclerosis; 2015 Dec; 243(2):553-9. PubMed ID: 26523993
[TBL] [Abstract][Full Text] [Related]
7. Effects of valsartan, an angiotensin II receptor blocker, on coronary atherosclerosis in patients with acute myocardial infarction who receive an angiotensin-converting enzyme inhibitor.
Yano H; Hibi K; Nozawa N; Ozaki H; Kusama I; Ebina T; Kosuge M; Tsukahara K; Okuda J; Morita S; Umemura S; Kimura K
Circ J; 2012; 76(6):1442-51. PubMed ID: 22473458
[TBL] [Abstract][Full Text] [Related]
8. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial.
Nissen SE; Nicholls SJ; Sipahi I; Libby P; Raichlen JS; Ballantyne CM; Davignon J; Erbel R; Fruchart JC; Tardif JC; Schoenhagen P; Crowe T; Cain V; Wolski K; Goormastic M; Tuzcu EM;
JAMA; 2006 Apr; 295(13):1556-65. PubMed ID: 16533939
[TBL] [Abstract][Full Text] [Related]
9. Do the extent and direction of arterial remodelling predict subsequent progression of coronary atherosclerosis? A serial intravascular ultrasound study.
Sipahi I; Tuzcu EM; Moon KW; Nicholls SJ; Schoenhagen P; Zhitnik J; Crowe TD; Kapadia S; Nissen SE
Heart; 2008 May; 94(5):623-7. PubMed ID: 18070944
[TBL] [Abstract][Full Text] [Related]
10. Comparison of intravascular ultrasound and quantitative coronary angiography for the assessment of coronary artery disease progression.
Berry C; L'Allier PL; Grégoire J; Lespérance J; Levesque S; Ibrahim R; Tardif JC
Circulation; 2007 Apr; 115(14):1851-7. PubMed ID: 17389269
[TBL] [Abstract][Full Text] [Related]
11. Intravascular ultrasound-derived measures of coronary atherosclerotic plaque burden and clinical outcome.
Nicholls SJ; Hsu A; Wolski K; Hu B; Bayturan O; Lavoie A; Uno K; Tuzcu EM; Nissen SE
J Am Coll Cardiol; 2010 May; 55(21):2399-407. PubMed ID: 20488313
[TBL] [Abstract][Full Text] [Related]
12. Progression of coronary atherosclerosis in stable patients with ultrasonic features of high-risk plaques.
Kataoka Y; Wolski K; Balog C; Uno K; Puri R; Tuzcu EM; Nissen SE; Nicholls SJ
Eur Heart J Cardiovasc Imaging; 2014 Sep; 15(9):1035-41. PubMed ID: 24780871
[TBL] [Abstract][Full Text] [Related]
13. Changes of coronary plaque composition correlate with C-reactive protein levels in patients with ST-elevation myocardial infarction following high-intensity statin therapy.
Koskinas KC; Zaugg S; Yamaji K; García-García HM; Taniwaki M; Klingenberg R; Moschovitis A; Lüscher TF; van Tits LJ; Matter CM; Windecker S; Räber L
Atherosclerosis; 2016 Apr; 247():154-60. PubMed ID: 26921743
[TBL] [Abstract][Full Text] [Related]
14. Impact of statins on serial coronary calcification during atheroma progression and regression.
Puri R; Nicholls SJ; Shao M; Kataoka Y; Uno K; Kapadia SR; Tuzcu EM; Nissen SE
J Am Coll Cardiol; 2015 Apr; 65(13):1273-1282. PubMed ID: 25835438
[TBL] [Abstract][Full Text] [Related]
15. Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial.
Nissen SE; Tuzcu EM; Libby P; Thompson PD; Ghali M; Garza D; Berman L; Shi H; Buebendorf E; Topol EJ;
JAMA; 2004 Nov; 292(18):2217-25. PubMed ID: 15536108
[TBL] [Abstract][Full Text] [Related]
16. Persistent Dysfunction of Coronary Endothelial Vasomotor Responses is Related to Atheroma Plaque Progression in the Infarct-Related Coronary Artery of AMI Survivors.
Horikoshi T; Obata JE; Nakamura T; Fujioka D; Watanabe Y; Nakamura K; Watanabe K; Saito Y; Kugiyama K
J Atheroscler Thromb; 2019 Dec; 26(12):1062-1074. PubMed ID: 30996201
[TBL] [Abstract][Full Text] [Related]
17. The angiotensin II receptor blocker candesartan cilexetil reduces neointima proliferation after coronary stent implantation: a prospective randomized study under intravascular ultrasound guidance.
Yoshida O; Hirayama H; Nanasato M; Watanabe T; Murohara T
Am Heart J; 2005 Jan; 149(1):e2. PubMed ID: 15660025
[TBL] [Abstract][Full Text] [Related]
18. Spotty calcification as a marker of accelerated progression of coronary atherosclerosis: insights from serial intravascular ultrasound.
Kataoka Y; Wolski K; Uno K; Puri R; Tuzcu EM; Nissen SE; Nicholls SJ
J Am Coll Cardiol; 2012 May; 59(18):1592-7. PubMed ID: 22538329
[TBL] [Abstract][Full Text] [Related]
19. Coronary plaque progression of non-culprit lesions after culprit percutaneous coronary intervention in patients with moderate to advanced chronic kidney disease: intravascular ultrasound and integrated backscatter intravascular ultrasound study.
Kashiyama K; Sonoda S; Muraoka Y; Suzuki Y; Kamezaki F; Tsuda Y; Araki M; Tamura M; Takeuchi M; Abe H; Okazaki M; Fujino Y; Otsuji Y
Int J Cardiovasc Imaging; 2015 Jun; 31(5):935-45. PubMed ID: 25724567
[TBL] [Abstract][Full Text] [Related]
20. Effect of aliskiren on progression of coronary disease in patients with prehypertension: the AQUARIUS randomized clinical trial.
Nicholls SJ; Bakris GL; Kastelein JJ; Menon V; Williams B; Armbrecht J; Brunel P; Nicolaides M; Hsu A; Hu B; Fang H; Puri R; Uno K; Kataoka Y; Bash D; Nissen SE
JAMA; 2013 Sep; 310(11):1135-44. PubMed ID: 23999933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
